Social stress engages opioid regulation of locus coeruleus norepinephrine neurons and induces a state of cellular and physical opiate dependence

Neuropsychopharmacology

Volumn 38, Issue 10, 2013, Pages 1833-1843

  Chaijale, Nayla N ^a   Curtis, Andre L ^a   Wood, Susan K ^a   Zhang, Xiao Yan ^a   Bhatnagar, Seema ^a   Reyes, Beverly As ^b   Van Bockstaele, Elisabeth J ^b   Valentino, Rita J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

corticotropin releasing factor; m opioid receptor; naloxone; opiate withdrawal; resident intruder

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; MU OPIATE RECEPTOR; NALOXONE; NORADRENALIN; OPIATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DENDRITE; DISEASE PREDISPOSITION; ELECTRON MICROSCOPY; GROOMING; LATENT PERIOD; LOCUS CERULEUS; MALE; MASTICATION; NONHUMAN; OPIATE ADDICTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RAT; SOCIAL STRESS; SUBSTANCE ABUSE; WESTERN BLOTTING;

OPIOID-RELATED DISORDERS; ACTION POTENTIALS; ADRENERGIC NEURONS; ANIMALS; LOCUS COERULEUS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, OPIOID, MU; STRESS, PSYCHOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84882450298     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.117     Document Type: Article

References (50)

1. Aghajanian GK (1978). Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276: 186-188.
2. Akaoka H, Aston-Jones G (1991). Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J Neurosci 11: 3830-3839.
3. Aston-Jones G, Hirata H, Akaoka H (1997). Local opiate withdrawal in locus coeruleus in vivo. Brain research 765: 331-336.
4. Bangasser DA, Curtis A, Reyes BA, Bethea TT, Parastatidis I, Ischiropoulos H et al (2010). Sex differences in corticotropinreleasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 15: 896-904.
5. Berenz EC, Coffey SF (2012). Treatment of co-occurring posttraumatic stress disorder and substance use disorders. Curr Psychiatry Rep 14: 469-477.
6. Caille S, Espejo EF, Reneric JP, Cador M, Koob GF, Stinus L (1999). Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther 290: 881-892.
7. Chan RKW, Sawchenko PE (1994). Spatially and temporally differentiated patterns of c-fos expression in brainstem catecholaminergic cell groups induced by cardiovascular challenges in the rat. J Comp Neurol 348: 433-460.
8. Conti LH, Foote SL (1995). Effects of pretreatment with corticotropin-releasing factor on the electrophysiological responsivity of the locus coeruleus to subsequent corticotropin- releasing factor challenge. Neuroscience 69: 209-219.
9. Conti LH, Foote SL (1996). Reciprocal cross-desensitization of locus coeruleus electrophysiological responsivity to corticotropin- releasing factor and stress. Brain Res 722: 19-29.
10. Cruz FC, Quadros IM, Hogenelst K, Planeta CS, Miczek KA (2011). Social defeat stress in rats: escalation of cocaine and 'speedball' binge self-Administration, but not heroin. Psychopharmacology 215: 165-175.
11. Curtis AL, Bello NT, Valentino RJ (2001). Endogenous opioids in the locus coeruleus function to limit the noradrenergic response to stress. J Neurosci 21: RC152.
12. Curtis AL, Florin-Lechner SM, Pavcovich LA, Valentino RJ (1997). Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J Pharmacol Exp Ther 281: 163-172.
13. Curtis AL, Leiser SC, Snyder K, Valentino RJ (2012). Predator stress engages corticotropin-releasing factor and opioid systems to alter the operating mode of locus coeruleus norepinephrine neurons. Neuropharmacology 62: 1737-1745.
14. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000). Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430-434.
15. Faravelli C, Lo Sauro C, Lelli L, Pietrini F, Lazzeretti L, Godini L et al (2012). The role of life events and HPA axis in anxiety disorders: a review. Curr Pharmaceutical Design 18: 5663-5674.
16. Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF (2007). Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-Administration in ethanol-dependent rats. Biol Psychiatry 61: 78-86.
17. Gold PW, Chrousos GP (2002). Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psych 7: 254-275.
18. Han MH, Bolanos CA, Green TA, Olson VG, Neve RL, Liu RJ et al (2006). Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors. J Neurosci 26: 4624-4629.
19. Heim C, Nemeroff CB (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 49: 1023-1039.
20. Jedema HP, Grace AA (2004). Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci 24: 9703-9713.
21. Kreibich A, Reyes BA, Curtis AL, Ecke L, Chavkin C, Van Bockstaele EJ et al (2008). Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system. J Neurosci 28: 6516-6525.
22. Maldonado R, Stinus L, Gold LH, Koob GF (1992). Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261: 669-677.
23. Mansour A, Fox CA, Thompson RC, Akil H, Watson SJ (1994). mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain research 643: 245-265.
24. McEwen BS (1998). Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci 840: 33-44.
25. Miczek KA (1979). A new test for aggression in rats without aversive stimulation: differential effects of d-Amphetamine and cocaine. Psychopharmacology (Berl) 60: 253-259.
26. Miczek KA (1991). Tolerance to the analgesic, but not discriminative stimulus effects of morphine after brief social defeat in rats. Psychopharmacology 104: 181-186.
27. Miczek KA, Covington HE 3rd, Nikulina EM Jr, Hammer RP (2004). Aggression and defeat: persistent effects on cocaine selfadministration and gene expression in peptidergic and aminergic mesocorticolimbic circuits. Neurosci Biobehav Rev 27: 787-802.
28. Miczek KA, Thompson ML, Shuster L (1986). Analgesia following defeat in an aggressive encounter: development of tolerance and changes in opioid receptors. Ann N Y Acad Sci 467: 14-29.
29. Mirzaii-Dizgah I, Karimian SM, Hajimashhadi Z, Riahi E, Ghasemi T (2008). Attenuation of morphine withdrawal signs by muscimol in the locus coeruleus of rats. Behav Pharmacol 19: 171-175.
30. Punch LJ, Self DW, Nestler EJ, Taylor JR (1997). Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci 17: 8520-8527.
31. Rasmussen K, Aghajanian GK (1989). Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis. Brain Res 505: 346-350.
32. Rasmussen K, Beitner-Johnson DB, Krystal JG, Aghajanian GK, Nestler EJ (1990). Opiate withdrawal and rat locus coeruleus: behavioral, electophysiological and biochemical correlates. J Neurosci 10: 2308-2317.
33. Reyes BA, Fox K, Valentino RJ, Van Bockstaele EJ (2006). Agonistinduced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur J Neurosci 23: 2991-2998.
34. Reyes BA, Valentino RJ, Van Bockstaele EJ (2008). Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 149: 122-130.
35. Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Armario A, Minarro J (2006). Social stress is as effective as physical stress in reinstating morphine-induced place preference in mice. Psychopharmacology 185: 459-470.
36. Rygula R, Abumaria N, Flugge G, Fuchs E, Ruther E, Havemann-Reinecke U (2005). Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav Brain Res 162: 127-134.
37. Schiff M, Levit S, Cohen-Moreno R (2010). Childhood sexual abuse, post-traumatic stress disorder, and use of heroin among female clients in Israeli methadone maintenance treatment programs (MMTPS). Social Work Health Care 49: 799-813.
38. Smagin GN, Swiergiel AH, Dunn AJ (1994). Sodium nitroprusside infusions activate cortical and hypothalamic noradrenergic systems in rats. Neurosci Res Comm 14: 85-91.
39. Southwick SM, Bremner JD, Rasmusson A, Morgan CA 3rd, Arnsten A, Charney DS (1999). Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 46: 1192-1204.
40. Taylor JR, Punch LJ, Elsworth JD (1998). A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat. Psychopharmacology (Berl) 138: 133-142.
41. Taylor PJ, Gooding P, Wood AM, Tarrier N (2011). The role of defeat and entrapment in depression, anxiety, and suicide. Psychological Bull 137: 391-420.
42. Valentino RJ, Page ME, Curtis AL (1991). Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res 555: 25-34.
43. Valentino RJ, Van Bockstaele E (2008). Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol 583: 194-203.
44. Valentino RJ, Wehby RG (1989). Locus coeruleus discharge characteristics of morphine-dependent rats: Effects of naltrexone. Brain Res 488: 126-134.
45. Van Bockstaele EJ, Branchereau P, Pickel VM (1995). Morphologically heterogeneous met-enkephalin terminals form synapses with tyrosine hydroxylase containing dendrites in the rat nucleus locus coeruleus: an immuno-electron microscopic analysis. J Comp Neurol 363: 423-438.
46. Van Bockstaele EJ, Colago EE, Valentino RJ (1996). Corticotropinreleasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol 364: 523-534.
47. Williams JT, North RA (1984). Opiate receptor interactions on single locus coeruleus neurons. Mol Pharm 26: 489-497.
48. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P et al (2000). Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 97: 325-330.
49. Wood SK, Walker HE, Valentino RJ, Bhatnagar S (2010). Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor. Endocrinology 151: 1795-1805.
50. Xu GP, Van Bockstaele E, Reyes B, Bethea T, Valentino RJ (2004). Chronic morphine sensitizes the brain norepinephrine system to corticotropin-releasing factor and stress. J Neurosci 24: 8193-8197..